4.7 Article

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations

Journal

CHEST
Volume 147, Issue 1, Pages 46-55

Publisher

ELSEVIER
DOI: 10.1378/chest.14-0764

Keywords

-

Funding

  1. Medical Research Council (UK)
  2. Wellcome Senior Fellowship
  3. National Institute for Health Research Post-Doctoral Fellowship
  4. European Regional Development Fund [ERDF 05567]
  5. MRC [G0601369, G0801980] Funding Source: UKRI
  6. Medical Research Council [G0801980, G0601369] Funding Source: researchfish
  7. National Institute for Health Research [NF-SI-0510-10157, NF-SI-0512-10018, PDF-2013-06-052] Funding Source: researchfish

Ask authors/readers for more resources

BACKGROUND: Relationships between airway inflammation and respiratory potentially pathogenic microorganisms (PPMs) quantified using quantitative polymerase chain reaction (qPCR) in subjects with COPD are unclear. Our aim was to evaluate mediators of airway inflammation and their association with PPMs in subjects with COPD at stable state and during exacerbations. METHODS: Sputum from 120 stable subjects with COPD was analyzed for bacteriology (colony-forming units; total 16S; and qPCR targeting Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae), differential cell counts, and inflammatory mediators using the Meso-Scale Discovery Platform. Subjects were classified as colonized if any PPM was identified above the threshold of detection by qPCR. Symptoms were quantified using the visual analog scale. RESULTS: At stable state, 60% of subjects were qPCR positive for H influenzae, 48% for M catarrhalis, and 28% for S pneumoniae. Elevated sputum concentrations of IL-1 beta, IL-10, and tumor necrosis factor (TNF)-alpha were detected in samples qPCR positive for either H influenzae or M catarrhalis. Bacterial loads of H influenzae positively correlated with IL-1 beta, IL-8, IL-10, TNF-alpha, and symptoms; and M catarrhalis correlated with IL-10 and TNF-alpha. H influenzae qPCR bacterial load was an independent predictor of sputum TNF-alpha and IL-1 beta. In 55 subjects with paired exacerbation data, qPCR bacterial load fold change at exacerbation in M catarrhalis but not H influenzae correlated to changes in sputum TNF-alpha and IL-1 beta concentrations. CONCLUSIONS: At stable state, H influenzae is associated with increased airway inflammation in COPD. The relationship between bacterial load changes of specific pathogens and airway inflammation at exacerbation and recovery warrants further investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Exhaled SARS-CoV-2 RNA viral load kinetics measured by facemask sampling associates with household transmission

Daniel Pan, Caroline M. Williams, Jonathan Decker, Eve Fletcher, Shirley Sze, Sara Assadi, Richard Haigh, Baber Saleem, Joshua Nazareth, Natalie J. Garton, Manish Pareek, Michael R. Barer

Summary: This study examines the longitudinal patterns of naturally exhaled SARS-CoV-2 RNA viral load during acute infection and the relationship between emitted RNA viral load and household transmission using facemask sampling (FMS). The results show that RNA viral load peaks within the first 5 days following sampling. The study also suggests that FMS can detect high levels of exhaled RNA viral load in early infection and is strongly associated with household transmission.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Immunology

Exhaled Mycobacterium tuberculosis Predicts Incident Infection in Household Contacts

Caroline M. Williams, Abdul K. Muhammad, Basil Sambou, Adama Bojang, Alhaji Jobe, Georgetta K. Daffeh, Olumuyiwa Owolabi, Daniel Pan, Manish Pareek, Michael R. Barer, Jayne S. Sutherland, Pranabashis Haldar

Summary: Mask sampling is a sensitive and noninvasive tool for evaluating the infectiousness of individuals in high tuberculosis (TB) burden settings. It provides better insight into community transmission and can inform public health interventions more reliably than sputum bacillary load.

CLINICAL INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Exhaled Pneumocystis jirovecii output and detection of asymptomatic exhalation by facemask sampling in HIV-uninfected, immunocompromised patients

M. T. Abdulwhhab, C. W. Holmes, J. Mutuyimana, S. S. F. Koo, A. Wisniewska, J. Auty, N. Perera, M. R. Barer

Summary: Uninfected patients suspected of having PJP can excrete P. jirovecii during normal respiration, indicating the need for further understanding of PJP transmission.

JOURNAL OF HOSPITAL INFECTION (2023)

Review Virology

Transmission of monkeypox/mpox virus: A narrative review of environmental, viral, host, and population factors in relation to the 2022 international outbreak

Daniel Pan, Joshua Nazareth, Shirley Sze, Christopher A. Martin, Jonathan Decker, Eve Fletcher, T. Deirdre Hollingsworth, Michael R. Barer, Manish Pareek, Julian W. Tang

Summary: Monkeypox virus (MPXV) has become a global concern. Recent studies have provided evidence on the transmission of MPXV, which can help in shaping evidence-based policies and dispelling misinformation. It has been found that viable viruses can survive on high-touch surfaces for up to 15 days. Sexual transmission appears to be the main route of transmission, with evidence of the virus present in saliva, nasopharynx, and sperm for prolonged periods. The current circulating variant of MPXV has shown milder clinical presentations and a higher transmissibility, particularly among men who have sex with men (MSMs).

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Primary Health Care

Effectiveness of exhaled nitric oxide for the prediction of non- invasive left atrial pressure in older people: a cross- sectional cohort study

Samuel Thomas Jones, Monica Londahl, Anthony Prothero, F. D. Richard Hobbs, Ian Pavord, Saul G. Myerson, Bernard Prendergast, Sean Coffey

Summary: This study investigated the relationship between FeNO and LAP in patients aged 65 and above, and found that FeNO was not an accurate predictor of elevated LAP.

BJGP OPEN (2023)

Article Allergy

Dupilumab improves long-term outcomes in patients with uncontrolled, moderate-to-severe GINA-based type 2 asthma, irrespective of allergic status

Klaus F. Rabe, Ian D. Pavord, William W. Busse, Geoffrey L. Chupp, Kenji Izuhara, Arman Altincatal, Rebecca Gall, Nami Pandit-Abid, Yamo Deniz, Paul J. Rowe, Juby A. Jacob-Nara, Amr Radwan

Summary: This study analyzed the efficacy of dupilumab in patients with or without evidence of allergic asthma and type 2 inflammation according to current GINA guidelines. The results showed that dupilumab reduced asthma exacerbation rates and improved lung function and asthma control, regardless of the presence of allergic asthma.

ALLERGY (2023)

Review Critical Care Medicine

Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease A Biologics Outlook

Klaus F. Rabe, Stephen Rennard, Fernando J. Martinez, Bartolome R. Celli, Dave Singh, Alberto Papi, Mona Bafadhel, Jigna Heble, Amr Radwan, Xavier Soler, Juby A. Jacob Nara, Yamo Deniz, Paul J. Rowe

Summary: COPD is a complex inflammatory airway disease with different types of inflammation, requiring targeted therapies and biomarkers for better management. Current treatments have limitations and there is a need for new strategies to address specific pathophysiological issues.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Review Immunology

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight

Imran Howell, Aleksandra Howell, Ian D. Pavord

Summary: The field of asthma has experienced significant changes recently, driven by advancements in our understanding of type 2 airway inflammation. The discovery of monoclonal antibodies targeting specific aspects of the immune pathway has led to successful trials showing efficacy in reducing asthma attacks and exposure to oral corticosteroids. This review examines the key features of type 2 inflammation in asthma, summarizes clinical trial evidence of novel monoclonal antibody treatments, and explores future avenues for targeted asthma treatment.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Letter Allergy

Clinically accessible biomarkers to assess the modifiable risk of asthma/wheezing attacks in toddlers

Simon Couillard, Francine M. Ducharme, Ian D. Pavord

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Allergy

Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics

William Walter Busse, Ian Douglas Pavord, Shahid Siddiqui, Asif Hameed Khan, Amy Praestgaard, Scott Nash, Juby Anne Jacob-Nara, Paul Jonathan Rowe, Yamo Deniz

Summary: The purpose of this study was to investigate the efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma. The results showed that dupilumab significantly improved the symptoms of both conditions, regardless of baseline asthma characteristics.

JOURNAL OF ASTHMA AND ALLERGY (2023)

Article Health Care Sciences & Services

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)

Imran Howell, Mahdi Mahdi, Mona Bafadhel, Timothy S. C. Hinks, Sanjay Ramakrishnan, James Melhorn, Maisha Jabeen, Ian D. Pavord

Summary: This study aims to compare the clinical recovery between high-FeNO and low-FeNO asthma attacks after acute treatment with oral prednisolone in patients established on long-term asthma mAb treatment. The study data will help power a future randomized placebo-controlled trial of prednisolone treatment for nonsevere attacks in patients treated with asthma mAbs and will provide important information on whether corticosteroid treatment should be FeNO-directed.

JMIR RESEARCH PROTOCOLS (2023)

Article Infectious Diseases

Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in- human study

Jie Zhou, Anika Singanayagam, Niluka Goonawardane, Maya Moshe, Fiachra P. Sweeney, Ksenia Sukhova, Ben Killingley, Mariya Kalinova, Alex J. Mann, Andrew P. Catchpole, Michael R. Barer, Neil M. Ferguson, Christopher Chiu, Wendy S. Barclay

Summary: This study aimed to compare viral emissions, viral load in the upper respiratory tract, and symptoms in participants experimentally infected with SARS-CoV-2. The results showed that a minority of participants were high airborne virus emitters, and the nose was identified as the most important source of emissions. Frequent self-testing and isolation upon the first symptom could reduce onward transmissions.

LANCET MICROBE (2023)

Article Allergy

Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of ICS dose

Ian D. D. Pavord, Arnaud Bourdin, Alberto Papi, Christian Domingo, Jonathan Corren, Arman Altincatal, Amr Radwan, Nami Pandit-Abid, Juby A. A. Jacob-Nara, Yamo Deniz, Paul J. J. Rowe, Elizabeth Laws, David J. J. Lederer, Megan Hardin

Summary: This study aimed to evaluate the long-term efficacy of dupilumab in patients on high- or medium-dose inhaled corticosteroids (ICS) at baseline. The study found that in patients on high-dose ICS, dupilumab showed sustained efficacy compared to placebo in terms of exacerbation rates, pre-bronchodilator forced expiratory volume in 1 second (FEV1), and asthma control questionnaire scores. Similar results were observed in patients on medium-dose ICS and in biomarker subgroups.

ALLERGY (2023)

Editorial Material Respiratory System

Which biologic? New findings from a real-world study

Gabriel Lavoie, Ian D. Pavord

RESPIROLOGY (2023)

Article Respiratory System

QRISK3 underestimates the risk of cardiovascular events in patients with COPD

Joseph Emil Amegadzie, Zhiwei Gao, Jennifer K. Quint, Richard Russell, John R. Hurst, Tae Yoon Lee, Don D. Sin, Wenjia Chen, Mona Bafadhel, Mohsen Sadatsafavi

Summary: Patients with COPD have a higher risk of cardiovascular disease. The accuracy of QRISK, a widely used CVD risk scoring tool, in capturing this excess risk is not well studied.

THORAX (2023)

No Data Available